AbCellera Biologics Inc. (ABCL) Discusses Phase II Top Line Results for ABCL635 in Treatment of Moderate-to-Severe Hot Flashes Transcript
· seekingalpha.com
AbCellera Biologics Inc. (ABCL) Discusses Phase II Top Line Results for ABCL635 in Treatment of Moderate-to-Severe Hot Flashes August 10, 2026 7:30 AM...
Presentation
Good afternoon, and welcome to the ABCL635 Phase II Clinical Update. My name is Jonathan, and I will facilitate the audio portion of today's inter...